Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD

被引:122
作者
Gompertz, S [1 ]
Bayley, DL [1 ]
Hill, SL [1 ]
Stockley, RA [1 ]
机构
[1] Queen Elizabeth Hosp, Lung Invest Unit, Dept Resp Med, Birmingham B15 2TH, W Midlands, England
关键词
chronic obstructive pulmonary disease; inflammation; secretory leukoprotease inhibitor (SLPI);
D O I
10.1136/thorax.56.1.36
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background-Patients with more frequent exacerbations of chronic obstructive pulmonary disease (COPD) may have increased bronchial inflammation. Airway inflammation was measured in patients who had been thoroughly investigated with full pulmonary function testing, thoracic HRCT scanning, and sputum microbiology to examine further the relationship between exacerbation frequency and bronchial inflammation. Methods-Airway inflammation (spontaneous sputum sol phase myeloperoxidase (MPO), elastase, leukotriene (LT)B-4, interleukin (IL)-8, secretory leukoprotenase inhibitor (SLPI), protein leakage) and serum levels of C reactive protein (CRP) were compared in 40 patients with stable, smoking related COPD, divided into those with frequent (greater than or equal to3/year) or infrequent (less than or equal to2/ year) exacerbations according to the number of primary care consultations during the preceding year. The comparisons were repeated after excluding eight otherwise clinically indistinguishable patients who had tubular bronchiectasis on the HRCT scan. Results-Patients with frequent (n=12) and infrequent (n=28) exacerbations were indistinguishable in terms of their clinical, pulmonary function, and sputum characteristics, CRP concentrations, and all of their bronchial inflammatory parameters (p>0.05). The patients without evidence of tubular bronchiectasis (n=32) were equally well matched but the sputum concentrations of SLPI were significantly lower in the frequent exacerbators (n=8) in this subset analysis (p<0.05). Conclusions-There are several clinical features that directly influence bronchial inflammation in COPD. When these were carefully controlled for, patients with more frequent reported exacerbations had lower sputum concentrations of SLPI. This important antiproteinase is also known to possess antibacterial and antiviral activity. Further studies are required into the nature of recurrent exacerbations and, in particular, the regulation and role of SLPI in affected individuals.
引用
收藏
页码:36 / 41
页数:6
相关论文
共 30 条
[1]   CORTICOSTEROIDS INCREASE SECRETORY LEUKOCYTE PROTEASE INHIBITOR TRANSCRIPT LEVELS IN AIRWAY EPITHELIAL-CELLS [J].
ABBINANTENISSEN, JM ;
SIMPSON, LG ;
LEIKAUF, GD .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1995, 268 (04) :L601-L606
[2]   ANTIBIOTIC-THERAPY IN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
ANTHONISEN, NR ;
MANFREDA, J ;
WARREN, CPW ;
HERSHFIELD, ES ;
HARDING, GKM ;
NELSON, NA .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) :196-204
[3]   NEBULIZER VS SPACER FOR BRONCHODILATOR DELIVERY IN PATIENTS HOSPITALIZED FOR ACUTE EXACERBATIONS OF COPD [J].
BERRY, RB ;
SHINTO, RA ;
WONG, FH ;
DESPARS, JA ;
LIGHT, RW .
CHEST, 1989, 96 (06) :1241-1246
[4]   Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations [J].
Bhowmik, A ;
Seemungal, TAR ;
Sapsford, RJ ;
Wedzicha, JA .
THORAX, 2000, 55 (02) :114-120
[5]   Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial [J].
Burge, PS ;
Calverley, PMA ;
Jones, PW ;
Spencer, S ;
Anderson, JA ;
Maslen, TK .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7245) :1297-1303
[6]   Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease [J].
Confalonieri, M ;
Mainardi, E ;
Della Porta, R ;
Bernorio, S ;
Gandola, L ;
Beghè, B ;
Spanevello, A .
THORAX, 1998, 53 (07) :583-585
[7]   Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis [J].
Gaga, M ;
Bentley, AM ;
Humbert, M ;
Barkans, J ;
O'Brien, F ;
Wathen, CG ;
Kay, AB ;
Durham, SR .
THORAX, 1998, 53 (08) :685-691
[8]  
Gompertz S, 2000, Semin Respir Infect, V15, P14
[9]  
GOMPERTZ S, 2000, IN PRESS EUR RESP J
[10]   Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis [J].
Hill, AT ;
Campbell, EJ ;
Hill, SL ;
Bayley, DL ;
Stockley, RA .
AMERICAN JOURNAL OF MEDICINE, 2000, 109 (04) :288-295